| pembrolizumab based treatment |
| pembrolizumab alone |
mGC or mGEJC - 1st line (L1) | |
mGC or mGEJC - L1 - all population | |
mGC or mGEJC - L1 - HER2 neg/PDL1 positive 2 | |
mGC or mGEJC - L1 - HER2 negative 1 | |
mGC or mGEJC - L1 - HER2 positive | |
mGC or mGEJC - L1 - PDL1 positive 4 | |
mGC or mGEJC - 2nd Line (L2) | |
mGC or mGEJC - L2 - all population 4 | |
mGC or mGEJC - L2 - PDL1 positive 1 | |
mGC or mGEJC - maintenance (M) | |
mGC or mGEJC - M - HER2 negative 1 | |
mGC or mGEJC - M - HER2 neg/PDL1 positive 1 | |